BRIEF-Danaher Announces Transition Plan For Chief Financial Officer [Reuters]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Reuters
BRIEF-Danaher Announces Transition Plan For Chief Financial Officer | Reuters Reuters Staff 1 Min Read Jan 30 (Reuters) - Danaher Corp: * DANAHER ANNOUNCES TRANSITION PLAN FOR CHIEF FINANCIAL OFFICER * DANAHER - EFFECTIVE JAN 1, 2019, MATTHEW R. MCGREW, GROUP CFO OF COMPANY‘S DIAGNOSTICS AND DENTAL PLATFORMS, WILL SUCCEED DANIEL L. COMAS AS CFO * DANAHER - COMAS WILL CONTINUE AS EXECUTIVE VICE PRESIDENT, MEMBER OF OFFICE OF CHIEF EXECUTIVE, EFFECTIVE JAN 1, 2019 Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. BRIEF-Danaher Announces Transition Plan For Chief Financial Officer Jan 30 (Reuters) - Danaher Corp: * DANAHER ANNOUNCES TRANSITION PLAN FOR CHIEF FINANCIAL OFFICER * DANAHER - EFFECTIVE JAN 1, 2019, MATTHEW R. MCGREW, GROUP CFO OF COMPANY‘S DIAGNOSTICS AND DENTAL PLATFORMS, WILL SUCCEED DANIEL L. COMAS AS CFO * DANAHER - COMAS WILL CON
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Oligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power [Yahoo! Finance]Yahoo! Finance
- Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at Citigroup Inc. from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at TD Cowen from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 4/25/24 - Form 4
- 4/25/24 - Form 4
- 4/25/24 - Form 144
- DHR's page on the SEC website